Enterprise AI Analysis
Accelerating AI innovation in healthcare: real-world clinical research applications on the Mayo Clinic Platform
The Mayo Clinic Platform (MCP) addresses challenges in real-world AI implementation by providing scalable, multi-institutional, de-identified data and analytical tools. This brief communication showcases MCP's capabilities through four research projects, demonstrating its ability to support efficient cohort identification, AI model development, and real-world evidence generation. MCP enhances accessibility and standardization, positioning it as a powerful platform for advancing translational research and precision medicine.
Key Impact Metrics
The Mayo Clinic Platform leverages vast, de-identified datasets to drive robust AI innovation and clinical research, transforming healthcare with unprecedented scale.
0
Patient Records
0
Radiology Images
0
Lab Results
0
Clinical Notes
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
The Mayo Clinic Platform provides a comprehensive workflow from data infrastructure to AI technology and clinical research projects, culminating in deliverable outcomes.
Enterprise Process Flow
Data Infrastructure & Tools
→
AI Technology
→
Clinical Research Projects
→
Deliverable Outcomes
MCP significantly reduces the time required for data collection and model training, accelerating research timelines.
1 Week
Time to collect structured EHR data for ~15,000 patients
This project demonstrated MCP's ability to stimulate Randomized Controlled Trials (RCTs) using real-world observational data. It offers a cost-effective alternative for evaluating treatment efficacy and led to the development of a reusable research pipeline.
Project 1: RCT Emulation for Heart Failure Drug Efficacy
Leveraging MCP's rich retrospective data, this project successfully emulated RCTs for heart failure drug efficacy. It provides a robust, cost-effective method to evaluate treatments, bypassing traditional RCT costs and ethical concerns. The outcome was a reusable pipeline for future RCT simulations.
A deep learning model (BiGRU) was validated using EHR data from diverse healthcare systems to predict Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) progression, showcasing AI's potential in early disease detection and its generalizability across datasets.
Project 3: MCI-to-AD Progression Prediction
Utilizing a BiGRU deep learning model, this project predicted the progression from MCI to AD using longitudinal EHR data. The model’s generalizability across diverse datasets from different healthcare systems validated its potential for early disease detection, improving clinical risk stratification.
The Mayo Clinic Platform offers distinct advantages over traditional institutional research repositories, including broader data access, extensive standardization, and integrated tools.
| Feature | MCP | Institutional Research Repositories |
|---|---|---|
| Data Access |
|
|
| Data Type |
|
|
| Data Standardization |
|
|
| Tool Accessibility |
|
|
| Learning Curve |
|
|
| Data Integration |
|
|
Calculate Your Potential ROI
Estimate the efficiency gains and cost savings your enterprise could achieve with advanced AI implementation based on industry benchmarks.
Annual Savings
Annual Hours Reclaimed
Accelerated Implementation Roadmap
Our strategic phased approach ensures a smooth and effective integration of AI into your enterprise, maximizing impact while minimizing disruption.
Phase 1: Data Integration & Standardization
Securely integrate diverse, multi-institutional real-world data into the OMOP CDM format, ensuring de-identification and privacy compliance. This foundational step establishes a unified, AI-ready dataset.
Phase 2: Platform Accessibility & Tooling
Provide a comprehensive suite of research tools, including code-free visualizers and advanced AI workspaces (JupyterLab, RStudio), enabling researchers with varying technical backgrounds to access and analyze data efficiently.
Phase 3: AI Model Development & Validation
Utilize MCP's high-performance computing resources to develop, train, and validate AI models, ensuring scalability, reproducibility, and generalizability across diverse datasets and healthcare systems.
Phase 4: Real-world Evidence Generation & Clinical Impact
Generate real-world evidence, validate existing studies, and accelerate translational medicine by deploying AI solutions into clinical workflows, ultimately enhancing patient care and precision healthcare.
Schedule Your AI Strategy Session
Ready to transform your healthcare initiatives with cutting-edge AI? Let's discuss how the Mayo Clinic Platform can accelerate your research and drive clinical innovation.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat